Paul M Guimond

Title: Paul M Guimond: Innovator in Feline Vaccine Development

Introduction

Paul M Guimond is a notable inventor based in Kalamazoo, MI (US). He has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for feline diseases. With a total of 4 patents, his work has had a profound impact on the health and well-being of cats.

Latest Patents

Guimond's latest patents focus on methods of vaccine administration and the development of new feline caliciviruses. One of his inventions relates to a vaccine composition against feline calicivirus (CFV) infection. This composition includes a capsid protein of Feline calicivirus-49 (CFV-49), a pharmaceutical accepted carrier, and optionally an adjuvant. Another patent describes a vaccine for immunizing cats against feline viruses, which includes a nucleic acid clone that encodes the capsid protein of the isolated feline calicivirus. His innovative methods also encompass the administration of vaccines to effectively immunize cats against diseases such as feline parvovirus and feline herpes virus.

Career Highlights

Throughout his career, Guimond has worked with prominent companies in the pharmaceutical industry, including Pharmacia & Upjohn Company and Pfizer Corporation. His experience in these organizations has allowed him to develop and refine his expertise in vaccine technology.

Collaborations

Guimond has collaborated with several professionals in his field, including Terry L Bowersock and Tzu-Chi R Ju. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Paul M Guimond's innovative work in feline vaccine development has made a significant impact on veterinary medicine. His contributions continue to enhance the health and immunization of cats against various diseases.